Literature DB >> 19146639

Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease.

H Sawada1, T Oeda, K Yamamoto, N Kitagawa, E Mizuta, R Hosokawa, M Ohba, R Nishio, K Yamakawa, H Takeuchi, S Shimohama, R Takahashi, T Kawamura.   

Abstract

BACKGROUND AND
PURPOSE: To estimate the diagnostic accuracy of cardiac (123)I-metaiodobenzylguanidine (MIBG) scintigram for detection of Parkinson disease.
METHODS: A cross-sectional study with index test of MIBG scintigram and reference standard of U.K. Parkinson's Disease Brain Bank Criteria was performed in 403 patients. Ratio of cardiac-to-mediastinum MIBG accumulation was determined at 20 min (early H/M) and 4 h (late H/M). Area under the receiver-operator characteristic (ROC) curve, sensitivity and specificity in detecting Parkinson disease were analyzed. Accuracy was analyzed in a subgroup of patients with disease duration of 3 years or less.
RESULTS: Area under the ROC curve was 0.89 using either early or late H/M as a diagnostic marker (95% CI 0.85-0.92 for early H/M and 0.86-0.93 for late H/M). Sensitivity and specificity were 81.3% (76.1-85.8%) and 85.0% (77.7-90.6%) for early H/M and 84.3% (79.3-88.4%) and 89.5% (83.01-94.1%) for late H/M. In the subgroup with duration of 3 years or less, the ROC curve area, sensitivity, and specificity were 0.86 (0.79-0.92), 76.0% (64.8-85.1%), and 83.9% (71.7-92.4%) for early H/M and 0.85 (0.78-0.92), 73.3% (61.9-82.9%), and 87.5% (75.9-94.8%) for late H/M.
CONCLUSION: Although diagnostic accuracy of cardiac MIBG scintigram is high, it is limited because of insufficient sensitivity in patients with short duration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19146639     DOI: 10.1111/j.1468-1331.2008.02372.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  23 in total

1.  Is (123)I-MIBG cardiac scintigraphy a surrogate marker for Parkinson's disease?

Authors:  Hidenao Fukuyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

2.  Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease.

Authors:  Africa Muxí; Pilar Paredes; Ignacio Navales; Francesc Valldeoriola; Carles Gaig; Francisco Lomeña; Andres de la Cerda; Oriol Solà; Beatriz Domenech; Eduardo Tolosa; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-04       Impact factor: 9.236

3.  Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease.

Authors:  Jin-Kyoung Oh; Eun-Kyoung Choi; In-Uk Song; Joong-Seok Kim; Yong-An Chung
Journal:  J Neural Transm (Vienna)       Date:  2015-05-24       Impact factor: 3.575

4.  Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA).

Authors:  B Tijero; J C Gomez-Esteban; V Llorens; E Lezcano; M C Gonzalez-Fernández; M Martinez de Pancorbo; J Ruiz-Martinez; J C Cembellin; J J Zarranz
Journal:  Clin Auton Res       Date:  2010-05-05       Impact factor: 4.435

5.  Evaluation of autonomic functions of patients with multiple system atrophy and Parkinson's disease by head-up tilt test.

Authors:  Chikako Watano; Yuri Shiota; Keiichi Onoda; Abdullah Md Sheikh; Seiji Mishima; Eri Nitta; Shozo Yano; Shuhei Yamaguchi; Atsushi Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-11-28       Impact factor: 3.575

Review 6.  MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.

Authors:  Giorgio Treglia; Ernesto Cason; Antonella Stefanelli; Fabrizio Cocciolillo; Daniela Di Giuda; Giorgio Fagioli; Alessandro Giordano
Journal:  Clin Auton Res       Date:  2011-07-27       Impact factor: 4.435

Review 7.  Pure Autonomic Failure.

Authors:  Elizabeth A Coon; Wolfgang Singer; Phillip A Low
Journal:  Mayo Clin Proc       Date:  2019-09-09       Impact factor: 7.616

Review 8.  PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases.

Authors:  Feng-Mei Lu; Zhen Yuan
Journal:  Quant Imaging Med Surg       Date:  2015-06

Review 9.  Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases.

Authors:  Giorgio Treglia; Ernesto Cason; Anna Gabellini; Alessandro Giordano; Giorgio Fagioli
Journal:  Neurol Sci       Date:  2010-03-10       Impact factor: 3.307

10.  [Clinical and imaging diagnostics of Parkinson's disease and multiple system atrophy].

Authors:  K I Schmidt; J Spiegel; W Reith
Journal:  Radiologe       Date:  2011-04       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.